Physical activity is a well-known defense against Alzheimer’s disease, and new research now clarifies how this protection works at a molecular level. A study from the University of California, San Francisco (UCSF) details how exercise boosts a specific protein that reinforces the brain’s natural defenses against inflammation and cognitive decline.
The Role of GPLD1 and TNAP in Brain Health
Researchers have long known that exercise increases glycosylphosphatidylinositol-specific phospholipase D1 (GPLD1) in the bloodstream. This protein is strongly linked to better brain function. The latest findings pinpoint how GPLD1 strengthens the blood-brain barrier, the gatekeeper against harmful substances that cause inflammation.
The key to this process lies in GPLD1’s interaction with tissue-nonspecific alkaline phosphatase (TNAP). TNAP typically keeps the blood-brain barrier permeable when the body is stressed, but it accumulates over time, weakening the barrier’s integrity. The UCSF team discovered that GPLD1 actively removes TNAP from the barrier’s cells, restoring its protective function.
How the Study Proved the Connection
Experiments on mice genetically engineered to either increase or decrease TNAP levels provided clear evidence. Mice with elevated TNAP exhibited cognitive decline similar to older animals. Conversely, reducing TNAP in older mice repaired leaks in the blood-brain barrier, lowered inflammation, and improved cognitive performance.
The research also linked GPLD1 and TNAP to amyloid beta plaques, the hallmark of Alzheimer’s. Increasing GPLD1 or lowering TNAP in mice with Alzheimer’s models reduced these harmful clumps, suggesting a direct impact on disease progression.
Implications for Treatment
The study demonstrates that exercise triggers GPLD1 production, which in turn regulates TNAP and strengthens the blood-brain barrier. This opens the door for potential therapies that mimic GPLD1’s effects synthetically, offering a way to protect cognitive function even without physical activity.
“We were able to tap into this mechanism late in life for the mice, and it still worked,” said neuroscientist Gregor Bieri, from UCSF.
What This Means for Humans
While the research was conducted on mice, the underlying biological processes are likely similar in humans. The blood-brain barrier protects against inflammation, a key factor in Alzheimer’s and other age-related cognitive decline. This study highlights the importance of systemic health—specifically, how the body influences brain function—a connection that has been historically overlooked.
Future research will focus on confirming these findings in humans and developing targeted interventions. The ultimate goal is to create treatments that replicate the cognitive benefits of exercise without requiring physical exertion. For now, this study reinforces the value of regular physical activity as a preventative measure against Alzheimer’s and cognitive decline.
